These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 7718875

  • 1. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR.
    Blood; 1995 Apr 15; 85(8):2025-37. PubMed ID: 7718875
    [Abstract] [Full Text] [Related]

  • 2. Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
    Grenzebach J, Schrappe M, Ludwig WD, Parwaresch R, Zimmermann M, Gadner H, Riehm H, Reiter A, BFM-Group.
    Ann Hematol; 2001 Apr 15; 80 Suppl 3():B73-6. PubMed ID: 11757713
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH, Cassileth PA, Leong T, Hoagland HC, Bennett JM, Paietta E, Oken MM, Eastern Cooperative Oncology Group Study.
    Leuk Lymphoma; 2003 Sep 15; 44(9):1515-21. PubMed ID: 14565653
    [Abstract] [Full Text] [Related]

  • 4. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group.
    Eur J Haematol; 2007 Feb 15; 78(2):102-10. PubMed ID: 17087744
    [Abstract] [Full Text] [Related]

  • 5. Treatment of adult acute lymphoblastic leukaemia.
    Jacobs P, Wood L, Novitzky N.
    Haematol Blood Transfus; 1990 Feb 15; 33():428-31. PubMed ID: 2323650
    [Abstract] [Full Text] [Related]

  • 6. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G.
    Haematologica; 1998 Sep 15; 83(9):791-9. PubMed ID: 9825576
    [Abstract] [Full Text] [Related]

  • 7. Treatment of acute lymphoblastic leukaemia (ALL).
    Jacobs P, Wood L.
    Eur J Haematol; 1992 Aug 15; 49(2):53-8. PubMed ID: 1397240
    [Abstract] [Full Text] [Related]

  • 8. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
    Chiu EK, Chan LC, Liang R, Lie A, Kwong YL, Todd D, Chan TK.
    Leukemia; 1994 Sep 15; 8(9):1469-73. PubMed ID: 8090027
    [Abstract] [Full Text] [Related]

  • 9. Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors.
    Park SR, Kim JH, Kim DY, Lee S, Lee SY, Choi IS, Yoon SS, Park S, Kim BG, Kim NK.
    Korean J Intern Med; 2003 Mar 15; 18(1):21-8. PubMed ID: 12760264
    [Abstract] [Full Text] [Related]

  • 10. Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
    Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, Grossman NJ, Kersey JH, Johnstone HS, Sather HN, Trigg ME, Uckun FM, Bleyer WA.
    Cancer; 1998 Feb 01; 82(3):600-12. PubMed ID: 9452280
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.
    Cherlow JM, Steinherz PG, Sather HN, Gaynon PS, Grossman NJ, Kersey JH, Johnstone HS, Breneman JC, Trigg ME, Hammond GD.
    Int J Radiat Oncol Biol Phys; 1993 Dec 01; 27(5):1001-9. PubMed ID: 8262820
    [Abstract] [Full Text] [Related]

  • 18. Randomized multicentric Italian study on two treatment regimens for marrow relapse in childhood acute lymphoblastic leukemia.
    Rossi MR, Masera G, Zurlo MG, Amadori S, Mandelli F, Bagnulo S, Carli M, Zanesco L, Dini G, Guazzelli C.
    Pediatr Hematol Oncol; 1986 Dec 01; 3(1):1-9. PubMed ID: 3153213
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E, Eguchi H, Matsuzaki A, Koga H, Yanai F, Kuroda H, Kawakami K, Ayukawa H, Akiyoshi K, Kamizono J, Tamai Y, Kinukawa N, Okamura J.
    Med Pediatr Oncol; 2001 Jul 01; 37(1):10-9. PubMed ID: 11466717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.